| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021335 |
| Receipt No. | R000024606 |
| Official scientific title of the study | Test of wearing object to wear. |
| Date of disclosure of the study information | 2016/04/01 |
| Last modified on | 2016/04/29 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Test of wearing object to wear. | |
| Title of the study (Brief title) | Test of wearing object to wear. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults and healthy infants. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Wearing test of the object to wear by the EMG and motion analysis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Subjective assessment of when attaching the object to wear. Muscle load of when attaching the object to wear. Motion analysis of when attaching the object to wear. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 6 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1.The subjects to make sure the wearing of the control products.
The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 2.The subjects to make sure the wearing of the object to wear A. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 3.The subjects to make sure the wearing of the object to wear B. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 4.The subjects to make sure the wearing of the object to wear C. The subjects tell the measurer When you finish the confirmation. Measurer is measured using the muscle load and motion analysis, and listening to the subjectivity. 5.Repeated 2 - 4 3 times. The measurement is a total of 9 trials. |
|
| Interventions/Control_2 | 1.The subjects to make sure the wearing of the control products.
The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 2.The subjects to make sure the wearing of the object to wear A. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 3.The subjects to make sure the wearing of the object to wear C. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 4.The subjects to make sure the wearing of the object to wear B. The subjects tell the measurer When you finish the confirmation. Measurer is measured using the muscle load and motion analysis, and listening to the subjectivity. 5.Repeated 2 - 4 3 times. The measurement is a total of 9 trials. |
|
| Interventions/Control_3 | 1.The subjects to make sure the wearing of the control products.
The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 2.The subjects to make sure the wearing of the object to wear B. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 3.The subjects to make sure the wearing of the object to wear A. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 4.The subjects to make sure the wearing of the object to wear C. The subjects tell the measurer When you finish the confirmation. Measurer is measured using the muscle load and motion analysis, and listening to the subjectivity. 5.Repeated 2 - 4 3 times. The measurement is a total of 9 trials. |
|
| Interventions/Control_4 | 1.The subjects to make sure the wearing of the control products.
The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 2.The subjects to make sure the wearing of the object to wear B. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 3.The subjects to make sure the wearing of the object to wear C. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 4.The subjects to make sure the wearing of the object to wear A. The subjects tell the measurer When you finish the confirmation. Measurer is measured using the muscle load and motion analysis, and listening to the subjectivity. 5.Repeated 2 - 4 3 times. The measurement is a total of 9 trials. |
|
| Interventions/Control_5 | 1.The subjects to make sure the wearing of the control products.
The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 2.The subjects to make sure the wearing of the object to wear C. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 3.The subjects to make sure the wearing of the object to wear A. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 4.The subjects to make sure the wearing of the object to wear B. The subjects tell the measurer When you finish the confirmation. Measurer is measured using the muscle load and motion analysis, and listening to the subjectivity. 5.Repeated 2 - 4 3 times. The measurement is a total of 9 trials. |
|
| Interventions/Control_6 | 1.The subjects to make sure the wearing of the control products.
The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 2.The subjects to make sure the wearing of the object to wear C. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 3.The subjects to make sure the wearing of the object to wear B. The subjects tell the measurer When you finish the confirmation. Measurer measures the muscle load and motion analysis, and listening to the subjectivity. 4.The subjects to make sure the wearing of the object to wear A. The subjects tell the measurer When you finish the confirmation. Measurer is measured using the muscle load and motion analysis, and listening to the subjectivity. 5.Repeated 2 - 4 3 times. The measurement is a total of 9 trials. |
|
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Protector
-Healthy. -A person who living with infant of research object. Infant -Healthy. |
|||
| Key exclusion criteria | Protector
-A person who feel pain in the body and changing diaper. Infant -Infants who are infected with dermatitis. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Niki Yoshifumi |
| Organization | Kao Corporation |
| Division name | R&D -Development Research- Personal Health Care Research Integrative Physiology Project. |
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN |
| TEL | 03-5630-9848 |
| niki.yoshifumi@kao.co.jp | |
| Public contact | |
| Name of contact person | Kanako Seo |
| Organization | Kao Corporation |
| Division name | R&D -Development Research- Personal Health Care Research Integrative Physiology Project. |
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN |
| TEL | 03-5630-7486 |
| Homepage URL | |
| seo.kanako@kao.co.jp | |
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社東京研究所(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024606 |